Meg Jardine's Publications

• Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial

  Journal articles

  2024

  BMJ open

• Canagliflozin and iron metabolism in the CREDENCE trial.

  Journal articles

  2024

  Nephrol Dial Transplant

• Risk of Relapse of Antineutrophil Cytoplasmic AntibodyAssociated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids

  Journal articles

  2024

  Arthritis and Rheumatology

• Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD A Meta-Analysis of CKD Progression Trials

  Journal articles

  2024

  Clinical Journal of the American Society of Nephrology

• Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial(Nature Medicine, 10.1038s41591-024-03043-1)

  Journal articles

  2024

  Nature Medicine

• Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials

  Journal articles

  2024

  The Lancet Diabetes and Endocrinology

• IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial

  Journal articles

  2024

  Nature Medicine

• Applications of SGLT2 inhibitors beyond glycaemic control

  Journal articles

  2024

  Nature Reviews Nephrology

• Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From 4 Large-Scale Placebo-Controlled Outcome Trials

  Journal articles

  2024

  Circulation

• Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study.

  Journal articles

  2024

  Nephrol Dial Transplant

• Authors Reply: Dialysate Sodium and Mortality: One Size Does Not Fit All

  Journal articles

  2024

  Journal of the American Society of Nephrology

• Adherence and persistence to novel glucose-lowering medications in persons with type 2 diabetes mellitus undergoing routine care

  Journal articles

  2024

  Diabetes Research and Clinical Practice

• Authors Reply: Dialysate Sodium and Mortality: 140 mmolL at Hemodialysis Initiation by Default?

  Journal articles

  2024

  Journal of the American Society of Nephrology

• The Efficacy and Safety of Reduced-Dose Oral Methylprednisolone in High-Risk Immunoglobulin A Nephropathy

  Journal articles

  2024

  Kidney International Reports

• Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

  Journal articles

  2024

  Circulation

• 1657 Impact of cumulative fluid and sodium imbalance exposure on cause-specific mortality in hemodialysis

  Journal articles

  2024

  Nephrology Dialysis Transplantation

• Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Results of an International Randomized Controlled Trial (PEXIVAS)

  Journal articles

  2024

  American Journal of Respiratory and Critical Care Medicine

• Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial

  Journal articles

  2024

  American Heart Journal

• Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

  Journal articles

  2024

  Kidney International Supplements

• Not enough known about fenofibrates kidney effects in people with Type 2 diabetes

  Journal articles

  2024

  Diabetes Research and Clinical Practice

• Calciphylaxis Episodes in the Australia and New Zealand Dialysis and Transplant Registry

  Journal articles

  2024

  Kidney International Reports

• Associations of Angiopoietin 2 and Vascular Endothelial Growth Factor-A Concentrations with Clinical End Points

  Journal articles

  2024

  Clinical Journal of the American Society of Nephrology

• Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data

  Journal articles

  2024

  The Lancet Regional Health - Western Pacific

• The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset

  Journal articles

  2024

  Kidney International Reports

• Are Observational Reports on the Association of Dialysate Sodium with Mortality Enough to Change Practice? Perspective from the RESOLVE Study Team

  Journal articles

  2024

  Journal of the American Society of Nephrology

• Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial

  Journal articles

  2024

  Kidney International Reports